Aspirin use for primary prevention is so last decade. But maybe it should be? Read how quantification of subclinical carotid atherosclerosis may help improve allocation of aspirin. #AHAJournals Omar Dzaye Michael J. Blaha Johns Hopkins Ciccarone Center ahajrnls.org/3LakW4y

So excited for new adventures in @mayoclinic Florida but will miss my Mayo ClinicCV friends in Rochester! Have learned so much during my RWJF health policy fellowship and National Academies. See you soon Melissa Lyle Abdallah El Sabbagh Mays Ali MD Carolyn Landolfo prajwal reddy

Life’s Necessary 9! Ignoring Mental Well-Being Is Costing Lives: Is it Time... sciencedirect.com/science/articl… Outstanding work by Adhya Mehta & Rishi Chandiramani Johns Hopkins Ciccarone Center Johns Hopkins Cardiology Johns Hopkins Medicine Thorsten Leucker #🥍🏏⛳️🏀⚾️

The sudden cardiac arrest (SCA) or death of a young athlete impacts beyond sports. High-profile cases like 𝐃𝐚𝐦𝐚𝐫 𝐇𝐚𝐦𝐥𝐢𝐧 & Bronny highlight the need for action. ✅Mandatory CPR training for all sports coaches

UPCOMING WEBINAR: Join us for the webinar, "Evaluation of Mitral Valve Prosthesis by Echocardiography," on August 22 at 6-7 PM ET! 🫀 Sign up: bit.ly/469uXZ9

Standing room only Mayo Clinic FL Medical Grand Rounds as my friend & colleague Awais Malik, M.D. takes the stage to present on #cardiacamyloidosis! An excellent overview of when to suspect cardiac amyloid, diagnostic criteria (notable mention Dan Davies, MD's risk score) & management.

Excited to share a new 🗞️ published in Circulation this week! Grateful for the opportunity to contribute to this important conversation on #AI for #HealthEquity ahajournals.org/doi/10.1161/CI… Mayo Clinic CV

An #AI model to detect HFpEF from an apical 4Ch video identified pts with increased risk of hospitalization for HF and cardiac mortality Mayo Clinic CV @Ultromics JASE Automated Echocardiographic Detection of Heart Failure With Preserved ... sciencedirect.com/science/articl…

We enrolled Intermediate surgical risk patient in the Mitral Valve-in-Valve Registry of PARTNER 3 trial. A total fo 50 patients were treated with TS MViV using the Sapien 3 THV, mean age 70 years, 54% female and mean STS-PROM of 4.1%. Technical success was 98%. The 26 mm S3 and

In a 36-wk study on #Aficamten for nHCM , 82.3% of pts reached 15–20mg/d with significant improvement in NYHA , KCCQ score, & #NTproBNP levels Read the full 📝 in this short report by Ahmad Masri et al. onlinelibrary.wiley.com/doi/full/10.10… #EJHF Giuseppe Galati Amr Abdin Henry Han

The mechanism of left ventricular outflow tract obstruction (LVOTO) is complex in hypertrophic cardiomyopathy (HCM). We aimed to evaluate the impact of mitral valve geometry on LVOTO by echocardiography. Read our JASE article: bit.ly/3LXwA32

What an honor and privilege, this lecture was just incredible! The learning experience in the FIT leadership academy is beyond I ever expected. Thank you Dr Kusumoto and to all the atendees. See you next month with Dr Rhea Sancassani, MD, FACC American College of Cardiology Florida Chapter ACC #FITLeadership

In the VALOR-HCM placebo-controlled trial of #mavacamten for symptomatic obstructive #cvHCM hypertrophic cardiomyopathy, mavacamten improved mitral valve SAM and regurgitation. bit.ly/46Alaf2 #JACCIMG Paul Cremer MD Milind Desai MD MBA Jeffrey Geske, MD

🆕 Amit Goyal MD MAS details the bRIGHT study, which offers a valuable glimpse into the real-world performance of the Abbott TriClip device. CardioNerds #interventionalcardiology #cardiology #cardiotwitter #cardioX Read Now❗: buff.ly/3ApUSQD

Experts from Mayo Clinic in HCM, Jeffrey Geske, MD, Steve Ommen, MD & Hartzell Schaff, MD, discuss the recent publication of the "2024 AHA/ACC/AMSSM/HRS/PACES/SCMR Guideline for the Management of Hypertrophic Cardiomyopathy". bit.ly/3WLkAGM

nature.com/articles/s4159… published today in Nature Medicine Many thanks to the entire study team in the US & Nigeria! Peter Noseworthy, MD Paul Friedman, MD Francisco Lopez-Jimenez, MD Zachi Attia Xiaoxi Yao Rickey Carter

We made so many great connections at #ESCCongress in London over the last 4 days. Cheers to European Society of Cardiology for organizing such an amazing event. We were thrilled to connect with cardiologists from all over the world along with many of our own Mayo Clinic colleagues.

This image hit me hard... I think of this as the Beginner's Paradox: You have to start poorly to end well. The most successful people I know love the feeling of being an embarrassing beginner. They thrive on that feeling of newness. They love diving into something with a

One week left to save $100 on the Mayo Clinic Echo Revolution #CME course! Our course directors Dr.Patricia Pellikka and @mdmankad have developed a world-class lineup of faculty and a robust program covering many aspects of #Echocardiography. Register today: mayocl.in/3MGVG6G

What are indications to use ultrasound enhancement agent (#UEA) in your clinical practice? On today's #CardiovascularCME Podcast, guests Jeremy Thaden and Mays Ali MD sit down with host Kyle W. Klarich to answer this question and more: …rdiovascularcmemayoclinic.podbean.com/e/iv-agents-to…